-
Mashup Score: 1
Analog Devices passed a milestone recently with FDA 510 (k) clearance and commercial launch of Sensinel, a remote, non-invasive Cardiopulmonary Management System. | Patients can apply adhesive sensors in ADI’s Sensinel to the chest for 3 to 5 minutes, collecting data that’s sent to a base station, then uploaded via cellular to the cloud for analysis
Source: www.fierceelectronics.comCategories: General Medicine News, Future of MedicineTweet
#Wearable Sensinel device detects subtle signs to monitor heart failure https://t.co/yTFpdzCZCQ https://t.co/cBumYkZVgk